Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

283 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical Features, Adverse Events and Treatment Outcomes of Multidrug/Rifampicin-resistant Tuberculosis in Children and Adolescents: An Eight-year Retrospective Cohort Study in Bandung, Indonesia.
Nataprawira HM, Gafar F, Sari CA, Alffenaar JC, Marais BJ, Ruslami R, Menzies D. Nataprawira HM, et al. Pediatr Infect Dis J. 2024 Sep 23;44(2):143-50. doi: 10.1097/INF.0000000000004539. Online ahead of print. Pediatr Infect Dis J. 2024. PMID: 39312636 Free PMC article.
Antibiotic De-Escalation Practices in the Intensive Care Unit: A Multicenter Observational Study.
Patanwala AE, Abu Sardaneh A, Alffenaar JC, Choo CL, Dey AL, Duffy EJ, Green SE, Hills TE, Howle LM, Joseph JA, Khuon MC, Koppen CS, Pang F, Park JY, Parlicki MA, Shah IS, Tran K, Tran P, Wills MA, Xu JH, Youssef M; ADEPT Study Investigators and Collaborators. Patanwala AE, et al. Ann Pharmacother. 2024 Aug 27:10600280241271223. doi: 10.1177/10600280241271223. Online ahead of print. Ann Pharmacother. 2024. PMID: 39192570
Comment on "Population Pharmacokinetics of Total and Unbound Isavuconazole in Critically Ill Patients: Implications for Adaptive Dosing Strategies" and "High Variability in Isavuconazole Unbound Fraction in Clinical Practice: A Call to Reconsider Pharmacokinetic/Pharmacodynamic Targets and Breakpoints".
Kong L, Alffenaar JC, Stocker SL. Kong L, et al. Clin Pharmacokinet. 2024 May;63(5):731-733. doi: 10.1007/s40262-024-01357-4. Epub 2024 Apr 4. Clin Pharmacokinet. 2024. PMID: 38573478 No abstract available.
283 results